# A Pharmacokinetic Evaluation of Metformin in Relation to the Polymorphism A270S in Healthy Caucasian Volunteers

> **NCT01237522** · PHASE4 · COMPLETED · sponsor: **University of Southern Denmark** · enrollment: 50 (actual)

## Conditions studied

- Metformin
- Organic Cation Transporter 2
- Polymorphism,Single Nucleotide

## Interventions

- **DRUG:** Metformin

## Key facts

- **NCT ID:** NCT01237522
- **Lead sponsor:** University of Southern Denmark
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-08
- **Primary completion:** 2010-12
- **Final completion:** 2010-12
- **Target enrollment:** 50 (ACTUAL)
- **Last updated:** 2010-12-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01237522

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01237522, "A Pharmacokinetic Evaluation of Metformin in Relation to the Polymorphism A270S in Healthy Caucasian Volunteers". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT01237522. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*